Hepatitis C virus 3b strains in injection drug users in Guangdong Province, China, may have originated in Yunnan Province

被引:11
作者
Wang, Min [1 ,2 ]
Liao, Qiao [1 ,2 ]
Xu, Ru [1 ,2 ]
Song, Dandan [1 ,3 ]
Huang, Jieting [1 ,2 ]
You, Qingzhu [4 ]
Shan, Zhengang [1 ,2 ]
Huang, Ke [1 ,2 ]
Rong, Xia [1 ,2 ,4 ]
Fu, Yongshui [1 ,2 ,4 ]
机构
[1] Guangzhou Blood Ctr, 31 Lu Yuan Rd, Guangzhou 510095, Guangdong, Peoples R China
[2] Key Med Disciplines & Specialties Program Guangzh, Guangzhou, Guangdong, Peoples R China
[3] Fifth Peoples Hosp Zhuhai, Zhuhai, Guangdong, Peoples R China
[4] Southern Med Univ, Sch Lab Med & Biotechnol, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
VOLUNTEER BLOOD-DONORS; MOLECULAR EPIDEMIOLOGY; GENOTYPE DISTRIBUTION; SUBTYPE DISTRIBUTION; GENETIC-ANALYSIS; HCV INFECTION; HEROIN USERS; RISK-FACTORS; PREVALENCE; TRANSMISSION;
D O I
10.1007/s00705-019-04260-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The distribution of hepatitis C virus (HCV) genotypes/subtypes varies among different populations. Here, we investigated HCV infection and its genotype distribution in injection drug users (IDUs) in Guangdong Province of China. A total of 318 IDUs from two prisons were recruited. The genotypes/subtypes of HCV in IDUs were determined by phylogenetic analysis using E1 and/or NS5B gene sequences. Our previous data on blood donors (BDs) with no history of drug use were used as control population data for comparison. Our results showed that the prevalence of HCV 3b (20.9% vs. 3.6%, P = 3.4E-9) and 6a (57.0% vs. 39.8%, P = 1.2E-5) was higher in IDUs than in BDs. In contrast, the prevalence of HCV 1b (43.4% vs. 5.6%, P = 9.8E-23) in BDs was higher than in IDUs. Phylogeographic analysis indicated that HCV 3b migrated from Yunnan to Guangdong Province and became endemic, with further transmission to other regions of China. The trend of HCV 3b dissemination in China in IDUs requires further attention, and a strategy for prevention and therapy is needed.
引用
收藏
页码:1761 / 1770
页数:10
相关论文
共 43 条
[1]   Perspectives for a vaccine against hepatitis C virus [J].
Abrignani, S ;
Houghton, M ;
Hsu, HH .
JOURNAL OF HEPATOLOGY, 1999, 31 :259-263
[2]   Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity [J].
Adinolfi, LE ;
Gambardella, M ;
Andreana, A ;
Tripodi, MF ;
Utili, R ;
Ruggiero, G .
HEPATOLOGY, 2001, 33 (06) :1358-1364
[3]   The importance of preventing hepatitis C virus infection among injection drug users in the United States [J].
Alter, MJ ;
Moyer, LA .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 18 :S6-S10
[4]  
[Anonymous], 2002, NIH Consens State Sci Statements, V19, P1
[5]   Hepatitis C virus infection and injection drug users: Prevention, risk factors, and treatment [J].
Backmund, M ;
Reimer, J ;
Meyer, K ;
Gerlach, JT ;
Zachoval, R .
CLINICAL INFECTIOUS DISEASES, 2005, 40 :S330-S335
[6]   Review of HIV and HCV infection among drug users in China [J].
Bao, Yan-ping ;
Liu, Zhi-min ;
Lu, Lin .
CURRENT OPINION IN PSYCHIATRY, 2010, 23 (03) :187-194
[7]   Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia [J].
Beyrer, C ;
Razak, MH ;
Lisam, K ;
Chen, J ;
Lui, W ;
Yu, XF .
AIDS, 2000, 14 (01) :75-83
[8]   Multiple Introduction and Naturally Occuring Drug Resistance of HCV among HIV-Infected Intravenous Drug Users in Yunnan: An Origin of China's HIV/HCV Epidemics [J].
Chen, Min ;
Ma, Yanling ;
Chen, Huichao ;
Luo, Hongbing ;
Dai, Jie ;
Song, Lijun ;
Yang, Chaojun ;
Mei, Jingyuan ;
Yang, Li ;
Dong, Lijuan ;
Jia, Manhong ;
Lu, Lin .
PLOS ONE, 2015, 10 (11)
[9]  
Chen Yuan-sheng, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P888
[10]   A genetic analysis of hepatitis Cvirus transmission between injection drug users [J].
Cochrane, A ;
Searle, B ;
Hardie, A ;
Robertson, R ;
Delahooke, T ;
Cameron, S ;
Tedder, RS ;
Dusheiko, GM ;
de Lamballerie, X ;
Simmonds, P .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (09) :1212-1221